Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications

被引:47
|
作者
Duque, Alice [1 ]
Mediano, Mauro Felippe Felix [1 ,2 ]
De Lorenzo, Andrea [1 ]
Rodrigues Jr, Luiz Fernando [1 ,3 ]
机构
[1] Inst Nacl Cardiol, Educ & Res Dept, Rua Laranjeiras 374, BR-22240006 Rio De Janeiro, RJ, Brazil
[2] Evandro Chagas Natl Inst Infect Dis, Oswaldo Cruz Fdn, Lab Clin Res Chagas Dis, BR-21040360 Rio De Janeiro, RJ, Brazil
[3] Univ Fed Rio de Janeiro, Inst Biomed, Dept Physiol Sci, BR-22240006 Rio De Janeiro, RJ, Brazil
关键词
Cardiovascular autonomic neuropathy; Cardiac autonomic neuropathy; Diabetes mellitus; Heart rate variability; Sympathetic autonomic nervous system; Parasympathetic autonomic nervous system; HEART-RATE-VARIABILITY; RISK-FACTORS; CARDIAC DENERVATION; OXIDATIVE STRESS; NERVOUS-SYSTEM; QT INTERVAL; MORTALITY; DIAGNOSIS; DYSFUNCTION; IMPACT;
D O I
10.4239/wjd.v12.i6.855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular autonomic neuropathy (CAN) is a debilitating condition that mainly occurs in long-standing type 2 diabetes patients but can manifest earlier, even before diabetes is diagnosed. CAN is a microvascular complication that results from lesions of the sympathetic and parasympathetic nerve fibers, which innervate the heart and blood vessels and promote alterations in cardiovascular autonomic control. The entire mechanism is still not elucidated, but several aspects of the pathophysiology of CAN have already been described, such as the production of advanced glycation end products, reactive oxygen species, nuclear factor kappa B, and pro-inflammatory cytokines. This microvascular complication is an important risk factor for silent myocardial ischemia, chronic kidney disease, myocardial dysfunction, major cardiovascular events, cardiac arrhythmias, and sudden death. It has also been suggested that, compared to other traditional cardiovascular risk factors, CAN progression may have a greater impact on cardiovascular disease development. However, CAN might be subclinical for several years, and a late diagnosis increases the mortality risk. The duration of the transition period from the subclinical to clinical stage remains unknown, but the progression of CAN is associated with a poor prognosis. Several tests can be used for CAN diagnosis, such as heart rate variability (HRV), cardiovascular autonomic reflex tests, and myocardial scintigraphy. Currently, it has already been described that CAN could be detected even during the subclinical stage through a reduction in HRV, which is a non-invasive test with a lower operating cost. Therefore, considering that diabetes mellitus is a global epidemic and that diabetic neuropathy is the most common chronic complication of diabetes, the early identification and treatment of CAN could be a key point to mitigate the morbidity and mortality associated with this long-lasting condition.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes
    Yun, Jae-Seung
    Park, Yong-Moon
    Cha, Seon-Ah
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [32] Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes
    Jae-Seung Yun
    Yong-Moon Park
    Seon-Ah Cha
    Yu-Bae Ahn
    Seung-Hyun Ko
    Cardiovascular Diabetology, 17
  • [33] Cardiac Autonomic Neuropathy in Diabetes - A clinical perspective
    Pop-Busui, Rodica
    DIABETES CARE, 2010, 33 (02) : 434 - 441
  • [34] ASSESSMENT OF CARDIOVASCULAR TESTS IN DIAGNOSIS OF DIABETIC AUTONOMIC NEUROPATHY
    FERNANDEZCASTANER, M
    FIGUEROLA, D
    SORRIBAS, A
    REYNALS, E
    BALCELLS, A
    DIABETES & METABOLISM, 1983, 9 (04): : 264 - 271
  • [35] ALIMENTARY AND CARDIOVASCULAR REFLEXES IN ASSESSMENT OF DIABETIC AUTONOMIC NEUROPATHY
    HOSKING, DJ
    BENNETT, T
    STEWART, IM
    HAMPTON, JR
    ATKINSON, M
    QUARTERLY JOURNAL OF MEDICINE, 1975, 44 (176): : 635 - 636
  • [36] Why Not to Use the Handgrip Test in the Assessment of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes Mellitus?
    Korei, Anna E.
    Kempler, Miklos
    Istenes, Ildiko
    Vagi, Orsolya E.
    Putz, Zsuzsanna
    Horvath, Viktor J.
    Keresztes, Katalin
    Lengyel, Csaba
    Tabak, Adam Gy.
    Spallone, Vincenza
    Kempler, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (01) : 66 - 73
  • [37] Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients
    Jermendy, G
    ACTA DIABETOLOGICA, 2003, 40 (Suppl 2) : S370 - S374
  • [38] Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients
    G. Jermendy
    Acta Diabetologica, 2003, 40 : s370 - s374
  • [39] Cardiovascular autonomic neuropathy: The clinical significance of its determination
    Maser, RE
    Lenhard, MJ
    DeCherney, GS
    ENDOCRINOLOGIST, 2000, 10 (01): : 27 - 33
  • [40] Increased risk of cardiovascular autonomic neuropathy (CAN) in hypertensive diabetes
    Yonemitsu, S
    Hayashi, T
    Masuda, I
    Azuma, N
    Nakano, M
    Tadamura, E
    Moritani, T
    DIABETES, 2000, 49 : A168 - A169